Search alternatives:
significant greatest » significant treatment (Expand Search), significant rates (Expand Search), significantly greater (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
significant greatest » significant treatment (Expand Search), significant rates (Expand Search), significantly greater (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
-
12941
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
12942
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
12943
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
12944
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
12945
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
12946
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
12947
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
12948
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
12949
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
12950
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
12951
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
12952
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
12953
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
12954
Table 1_Relationship between nocturia, depression, and cognitive function and the mediating effects of nutritional indexes in older adults: data from NHANES 2011–2014.docx
Published 2025“…Thus, improving nutrition may decrease the risk of nocturia in older adults.</p>…”
-
12955
Results of Welch’s t-test.
Published 2025“…<div><p>The COVID-19 pandemic triggered social and economic stagnation worldwide, significantly impacting people’s lives. In addition, the Russia-Ukraine war that began in 2022 resulted in rising food prices globally, severely affecting low- and middle-income countries. …”
-
12956
<b>Metabolic shifts in ratio of ucOcn to cOcn towards bone resorption contribute to age-dependent bone loss in male mice</b>
Published 2024“…Our findings further demonstrated that the increase in osteoclast activity and the decrease in osteoblast function were significantly corelated with blood levels of ucOcn and cOcn, respectively. …”
-
12957
Table 1_Molecular hybridization modification improves the stability and immunomodulatory activity of TP5 peptide.docx
Published 2024“…The half-life of YTP in plasma is significantly longer than that of YW12D and TP5. YTP also displays an improved ability to protect the host from CTX-induced weight loss and thymus and spleen indices decrease than YW12D and TP5. …”
-
12958
Urbanization and climate jointly shape the composition of plant life forms
Published 2024“…The compositions of plant life forms were significantly controlled by urbanization intensity and annual mean temperature. …”
-
12959
Table 1_The effects of trace element supplementation on glycolipid metabolism in PCOS: a systematic review and meta-analysis.docx
Published 2025“…The results showed a significant decrease in fasting blood glucose levels (SMD = −0.79, 95% CI: −1.11 to −0.46). …”
-
12960
Table 2_The global burden of pediatric infective endocarditis (5–14 years): epidemiological patterns from 1990 to 2021 and projected trajectories.pdf
Published 2025“…</p>Results<p>Globally, the incidence of pediatric IE declined by 27.6% (95% UI, −30.9% to −24.9%) and mortality by 21.4% (95% UI, −35.2% to −0.8%) between 1990 and 2021, with an estimated annual percentage change (EAPC) of −1.37% (95% CI, −1.49% to −1.24%) and −0.64% (95% CI, −0.75% to −0.54%), respectively. DALYs decreased by 19.2% (95% UI, −33.2% to 1.9%). Marked disparities persisted, with high-SDI regions, notably China, achieving the greatest reductions in burden, while sub-Saharan Africa and Eastern Europe exhibited stagnant or increasing rates. …”